Tag: heart disease
MTPConnect launches $28.5M funding to boost heart disease, diabetes innovations
MTPConnect announced the opening of a $28.5 million funding opportunity aimed at accelerating the development of new drugs and devices for heart disease and diabetes.Â
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
